Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Find out when funds are available after a deposit, including standard windows and factors that can affect arrival times.
21,612 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Li Auto unveiled a $1 billion share repurchase after weaker Q4 deliveries, sending LI higher and triggering a debate ...
Mortgage rates jump to the mid-6% range as geopolitical risk rises, pushing borrowing costs closer than 7% and compli...
Rising longevity, tax complexity, and market volatility are forcing retirees to rethink the old retirement playbook. ...
Chip-led gains push the Nasdaq Composite higher as oil retreats and jobs data beat expectations, setting the stage fo...
Airbnb (ABNB) enters 2026 with evolving monetization and travel demand. This guide breaks down Q1 insights, margins, ...
Rising rates don’t have to stop your rental plans. This guide breaks down actionable strategies to land cash-flowing ...
Imagine paying one universal rate on every dollar you earn. This article breaks down the flat tax idea, how it differ...
Life360 delivered a strong quarter, but user growth hiccups and a lofty valuation rattled investors. This piece break...
Pfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
DLocal faces a pivotal year as Q1 2026 results shape the path to 2026 earnings. This guide breaks down the key metric...
Greg Abel, stepping into Warren Buffett's shadow, has quietly tripled Berkshire's Alphabet stake. Is this the kind of...